Brown Miller Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.7M Sell
3,921
-50
-1% -$51.1K 1.18% 20
2026
Q1
$3.65M Buy
3,971
+17
+0.4% +$17.2K 1.04% 22
2025
Q4
$4.25M Hold
3,954
1.17% 16
2025
Q3
$3.02M Buy
3,954
+3,620
+1,084% +$2.69M 0.86% 28
2025
Q2
$260K Sell
334
-14
-4% -$10.9K 0.08% 166
2025
Q1
$288K Buy
+348
New +$290K 0.1% 147
2024
Q4
Sell
-445
Closed -$394K 128
2024
Q3
$394K Buy
445
+119
+37% +$107K 0.15% 86
2024
Q2
$295K Buy
326
+13
+4% +$10.4K 0.12% 101
2024
Q1
$244K Buy
+313
New +$223K 0.11% 112

Other funds holding LLY

Brown Miller Wealth Management's LLY Position: Q2 2026 in Review

Brown Miller Wealth Management reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $51.1K and leaving 3,921 shares worth $4.7M. The position accounts for 1.18% of the portfolio, ranked #20.

Brown Miller Wealth Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Brown Miller Wealth Management held 3,921 shares of Eli Lilly worth $4.7M as of Q2 2026.
  • Brown Miller Wealth Management sold 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
  • Eli Lilly made up 1.18% of Brown Miller Wealth Management's portfolio in Q2 2026, its #20 holding.
  • Brown Miller Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brown Miller Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.